123 related articles for article (PubMed ID: 3697953)
1. Differences in the covalent binding of benzo[a]pyrene, safrole, 1'-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice.
Lu LJ; Disher RM; Randerath K
Cancer Lett; 1986 Apr; 31(1):43-52. PubMed ID: 3697953
[TBL] [Abstract][Full Text] [Related]
2. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
3. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
5. A comparison of DNA adduct formation in white blood cells and internal organs of mice exposed to benzo[a]pyrene, dibenzo[c,g]carbazole, safrole and cigarette smoke condensate.
Reddy MV; Randerath K
Mutat Res; 1990 May; 241(1):37-48. PubMed ID: 2333084
[TBL] [Abstract][Full Text] [Related]
6. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the intercalative binding of non-reactive benzo[a]pyrene metabolites and metabolite model compounds to DNA.
Abramovich M; Prakash AS; Harvey RG; Zegar IS; Lebreton PR
Chem Biol Interact; 1985 Oct; 55(1-2):39-62. PubMed ID: 3933843
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
Adriaenssens PI; White CM; Anderson MW
Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
[TBL] [Abstract][Full Text] [Related]
9. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
Rojas M; Alexandrov K
Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285
[TBL] [Abstract][Full Text] [Related]
10. Comparison of DNA adduct formation in mice fed coal tar or benzo[a]pyrene.
Culp SJ; Beland FA
Carcinogenesis; 1994 Feb; 15(2):247-52. PubMed ID: 8313515
[TBL] [Abstract][Full Text] [Related]
11. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.
Wislocki PG; Borchert P; Miller JA; Miller EC
Cancer Res; 1976 May; 36(5):1686-95. PubMed ID: 5188
[TBL] [Abstract][Full Text] [Related]
12. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
13. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.
Boberg EW; Miller EC; Miller JA; Poland A; Liem A
Cancer Res; 1983 Nov; 43(11):5163-73. PubMed ID: 6577945
[TBL] [Abstract][Full Text] [Related]
14. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
Reddy MV; Randerath K
Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
[TBL] [Abstract][Full Text] [Related]
15. Carcinogen-DNA adducts in cultures of rat and human hepatocytes.
Monteith DK; Gupta RC
Cancer Lett; 1992 Feb; 62(1):87-93. PubMed ID: 1540936
[TBL] [Abstract][Full Text] [Related]
16. Modulation of benzo[a]pyrene-induced covalent DNA modifications in adult and fetal mouse tissues by gestation stage.
Lu LJ; Wang MY
Carcinogenesis; 1990 Aug; 11(8):1367-72. PubMed ID: 2387022
[TBL] [Abstract][Full Text] [Related]
17. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse.
Sticha KR; Staretz ME; Wang M; Liang H; Kenney PM; Hecht SS
Carcinogenesis; 2000 Sep; 21(9):1711-9. PubMed ID: 10964103
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
Randerath K; Moorthy B; Mabon N; Sriram P
Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
[TBL] [Abstract][Full Text] [Related]
19. Role of cytochrome P4501B1 in benzo[a]pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates.
Moorthy B; Miller KP; Jiang W; Williams ES; Kondraganti SR; Ramos KS
J Pharmacol Exp Ther; 2003 Apr; 305(1):394-401. PubMed ID: 12649394
[TBL] [Abstract][Full Text] [Related]
20. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
